|Videos|August 28, 2020
What’s new in vitiligo treatment?
Author(s)Jessica Barry
Expert Seemal R. Desai, M.D., FAAD, highlights new therapeutics that may impact the future of vitiligo management, a topic he discussed at the AAD Virtual Meeting Experience (VMX) in June.
Advertisement
“I think that JAK inhibitors are really exciting right now in our quest to find an effective, long-term, safe treatment - as well as potentially a cure for vitiligo,” says Dr. Desai. Find out how he uses these medications in the video below.
In case you missed it: Dr. Desai talks about
More from Dr. Desai:
Talk to your vitiligo patients about their treatment goals How to classify disease activity in vitiligo patients Best practices for unstable vitiligo
Stay tuned: Up next, Dr. Desai explains confetti vitiligo and trichrome vitiligo.
For more about AAD VMX,
Reference
Desai S. What's New in Vitiligo. Therapeutic Hotline. AAD VMX 2020; June 12, 2020.
Newsletter
Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.
Advertisement
Related Content
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Dermatology Times
1
Clascoterone 5% Delivers Strong Phase 3 Hair-Growth Results
2
Derm Dispatch: What 'Free to Be Me' Means to Tori Spelling and Stella McDermott
3
Alpha-9 Begins First-in-Human Trial of MC1R-Targeted Radiotherapeutic
4
Dermatology Conferences and Meetings Calendar: December 2025
5
